The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning

Clinical Toxicology

Volumn 49, Issue 5, 2011, Pages 366-373

  Chan, Adriano ^a,b   Crankshaw, Daune L ^c   Monteil, Alexandre ^c   Patterson, Steven E ^c   Nagasawa, Herbert T ^c   Briggs, Jackie E ^c   Kozocas, Joseph A ^d   Mahon, Sari B ^e   Brenner, Matthew ^e   Pilz, Renate B ^a   Bigby, Timothy D ^a,b   Boss, Gerry R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d SRI INTERNATIONAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inhalation exposure; Intramuscular injection; Lethal model; Non lethal model

Indexed keywords

3 MERCAPTOPYRUVIC ACID; ANTIDOTE; COBINAMIDE; CYANIDE; SULFANEGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYANIDE POISONING; DRUG POTENTIATION; MALE; MONOTHERAPY; MOUSE; NONHUMAN;

ANIMALS; ANTIDOTES; COBAMIDES; CYANIDES; CYSTEINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; MALE; MICE; MICE, INBRED C57BL; PRODRUGS;

ANIMALIA; MUS;

EID: 79960278822     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.584879     Document Type: Article

References (35)

1. Dzomback DA, Ghosh RS, Wong-Chong GM. Cyanide in Water and Soil: Chemistry, Risk, and Management. Boca Raton, FL: CRC Press; 2006.
2. Alarie Y. Toxicity of fi re smoke. Crit Rev Toxicol 2002; 4:259-289.
3. Baud FJ, Barriot P, Toffi s V, Riou B, Vicaut E, Lecarpentier Y, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991; 325:1761-1766.
4. Ernesto M, Cardoso AP, Nicala D, Mirione E, Massaza F, Cliff J, et al. Persistent konzo and cyanogen toxicity from cassava in northern Mozambique. Acta Trop 2002; 82:357-362. (Pubitemid 34556973)
5. Cottrell JE, Casthely P, Brodie JD, Patel K, Klein A, Turndorf H. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med 1978; 298:809-811. (Pubitemid 8313453)
6. Broughton E. The Bhopal disaster and its aftermath: a review. Environ Health 2005;4:6-15.
7. Verma DR. Hydrogen cyanide and Bhopal. Lancet 1989; 334: 567-568.
8. James Martin Center for Nonproliferation Studies. Chronology of Aum Shinrikyo ' s CBW Activities. http://cns.miis.edu/reports/pdfs/aum-chm.pdf.
9. Joseph Konopka. http://en.widipedia.org/wiki/Joseph-Konopka.
10. Suskin R. The One Percent Doctrine: Deep Inside America' s Pursuit of its Enemies since 9/11. New York: Simon & Schuster; 2006.
11. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007; 49:794-801.
12. Way JL. Cyanide intoxication and its mechanism of antagonism. Annu Rev Pharmacol Toxicol 1984; 24:451-481. (Pubitemid 14129543)
13. Gracia R, Shepherd G. Cyanide poisoning and its treatment. Pharmacotherapy 2004; 24:1358-1365. (Pubitemid 39304999)
14. Hayward GC, Hill HAO, Pratt JM, Vanston NJ, Williams ARW. The chemistry of vitamin B(12). Part IV. 1 The thermodynamic trans-effect. J Chem Soc 1965; 6485-6493.
15. Chan A, Balasubramanian M, Blackledge W, Mohammad OM, Alvarez L, Boss GR, Bigby TD. Cobinamide is superior to other treatments in a mouse model of cyanide poisoning. Clin Toxicol (Phila) 2010; 48:709-717.
16. Brenner M, Kim JG, Mahon SB, Lee J, Kreuter KA, Blackledge W, et al. Intramuscular cobinamide sulfi te in a rabbit model of sublethal cyanide toxicity. Ann Emerg Med 2009; 55:352-363.
17. Sharma VS, Pilz RB, Boss GB, Magde D. Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide. Biochemistry 2003; 42:8900-8908. (Pubitemid 36899834)
18. Broderick KE, Singh V, Zhuang S, Kambo A, Chen JC, Sharma VS, et al. Nitric oxide scavenging by the cobalamin precursor cobinamide. J Biol Chem 2005; 280:8678-8685. (Pubitemid 40409555)
19. Pearce LL, Bominaar EL, Hill BC, Peterson J. Reversal of cyanide inhibition of cytochrome c oxidase by the auxiliary substrate nitric oxide. J Biol Chem 2003; 278:52139-52145. (Pubitemid 38035800)
20. Leavesley HB, Li L, Prabhakaran K, Borowitz JL, Isom GE. Interaction of cyanide and nitric oxide with cytochrome c oxidase: implications for acute cyanide toxicity. Toxicol Sci 2008; 101:101-111. (Pubitemid 350252853)
21. Nazifi S, Aminlari M, Alaibakhsh MA. Distribution of rhodanese in tissues of goat (Capra hircus). Comp Biochem Physiol B Biochem Mol Biol 2003; 134:515-518. (Pubitemid 36293757)
22. Sylvester M, Sander C. Immunohistochemical localization of rhodanese. Histochem J 1990; 22:197-200. (Pubitemid 20212102)
23. Nagahara N, Ito T, Minami M. Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxifi cation. Histol Histopathol 1999; 14:1277-1286. (Pubitemid 29447468)
24. Nagahara N, Okazaki T, Nishino T. Cytosolic mercaptopyruvate sulfurtransferase is evolutionarily related to mitochondrial rhodanese. Striking similarity in active site amino acid sequence and the increase in the mercaptopyruvate sulfurtransferase activity of rhodanese by site-directed mutagenesis. J Biol Chem 1995; 270: 16230-16235.
25. Nagasawa HT, Goon DJ, Crankshaw DL, Vince R, Patterson SE. Novel, orally effective cyanide antidotes. J Med Chem 2007; 50:6462-6464. (Pubitemid 350309085)
26. Brenner M, Kim JG, Lee J, Mahon SB, Lemor D, Ahdout R, et al. Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity. Toxicol Appl Pharmacol 2010; 248:269-276.
27. Coughenour LL, Mclean JR, Parker RB. A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 1977; 6:351-353. (Pubitemid 8084883)
28. Crankshaw DL, Goon DJW, Briggs JE, DeLong D, Kuskowski M, Patterson SE, Nagaswa HT. A novel paradigm for assessing effi cacies of potential antidotes against neurotoxins in mice. Toxicol Lett 2007; 175:111-117. (Pubitemid 350116479)
29. Salkowski AA, Penney DG. Cyanide poisoning in animals and humans: a review. Vet Hum Toxicol 1994; 36:455-466. (Pubitemid 24300068)
30. Evans CL. Cobalt compounds as antidotes for hydrocyanic acid. Br J Pharmacol Chemother 1964; 23:455-475.
31. Hall AH, Rumack BH. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med 1987; 5:115-121. (Pubitemid 17063029)
32. Bebarta VS, Tanen DA, Lairet J, Dixon PS, Valtier S, Bush A. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2010; 55:345-351.
33. Borron SW, Stonerook M, Reid F. Effi cacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 2006; 44 Suppl 1:5-15. (Pubitemid 44451795)
34. Ivankovich AD, Braverman B, Kanuru RP, Heyman HJ, Paulissian R. Cyanide antidotes and methods of their administration in dogs: a comparative study. Anesthesiology 1980; 52:210-216. (Pubitemid 10176858)
35. Posner MA, Tobey RE, McElroy H. Hydroxocobalamin therapy of cyanide intoxication in guinea pigs. Anesthesiology 1976; 44:157-160.